Charles Mueller, PhD

Dr. Charles Mueller is a researcher with extensive experience developing models of new and existing policies and designing methodologies to assess policy effectiveness.

Research Associate

Organization:

West Virginia University Health Sciences Center

Department:

Health Affairs Institute

Classification:

Staff

• PhD, Biochemistry, University of Maryland
• BA, Chemistry, Elon University

Mueller CW. Biological Characterization of Two Putative DNA Metabolism Enzymes in Deinococcus radiodurans, Chemistry &Biochemistry Theses and Dissertations, Digital Repository at the University of Maryland, 2014. http://hdl.handle.net/1903/16082

Cao Z., Mueller CW, Julin DA. Analysis of the recJ gene and protein from Dienococcus radiodurans, DNA Repair, 2009, (9), 66-75.

Carlson BA, Yoo MH, Tobe R, Mueller C, Narajo-Suarez S, Hoffmann VJ, Gladyshev VN, Hatfield D. Thioredoxin reductase1 protects against chemically induced hepatocarcinogenesis via control of cellular redox homeostasis, Carcinogenesis, 2012, (9); 1806-13.

Mueller C, Reimagining the American Dream, STEPS Magazine, Potomac Institute Press, Issue 4, p. 40-43, 2016. (Online) 2153-3679

Mueller C, McCauley Rench R, Syers P, Organizing Chaos: A Unified Vision for S&T, STEPS Magazine, Potomac Institute Press, Issue 4, p. 44-50, 2016. ISSN (Online) 2153-3679.

Hummel R, Pera R, Mueller C. The Decline & Fall of the ITAR Empire, STEPS Magazine, Potomac Institute Press, Issue 2, p. 38-45, 2015.
Mueller C, Alternative Futures for Corrosion & Degradation Research: Impact of Atomic Effects Corrosion on Materials Sustainment, Potomac Institute Press, 2015, ISBN 978-0-9963960-1-1

Mueller, C, Creativity in Science: Fostering Failure, STEPS Magazine, Potomac Institute Press, Issue 1, p. 44-47, 2015. ISSN (Online) 2153-3679.

In his role with the Office of Health Affairs, Charles provides research and policy development for the WV DHHR. His work currently centers on the COVID-19 Evaluation Project, which involves scanning WV DHHR Bureau for Medical Services policy changes made in response to the COVID-19 pandemic and creating logic models to guide development of an evaluation plan for these policy changes.

Prior to joining the team at the Office of Health Affairs, Charles' work centered on policy evaluation in the private and public sector. He was a research fellow at the Center for Revolutionary and Extraordinary Scientific Thought at Potomac Institute for Policy Studies, where he worked with a team to develop solutions to future science and technology policy issues, such as the emergence and impacts of AI and served as Director of the Regulatory Science & Engineering Center at Potomac Institute, promoting the creation of policy using scientific principles. He also worked with agencies like NASA in developing technology readiness, assessment, and forecasting methodologies.